Form 4: 10x Genomics Executive Benjamin J. Hindson Sells Shares to Cover Tax Obligations

Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, sold 4,087 shares of Class A Common Stock on May 22, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 22, 2024, Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, sold 4,087 shares of Class A Common Stock.
• The shares were sold at a price of $24.3036 per share.
• The transaction was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Hindson directly owns 350,055 shares of 10x Genomics Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction to cover tax obligations and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations when restricted stock units vest. These transactions are publicly disclosed to maintain transparency and prevent insider trading.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on other stakeholders.

Key Dates